Sponsored by Novartis Pharmaceuticals Corporation

In this Dermatology Times Partner Perspectives video, Dr. Amit Garg explores the evolving diagnostic landscape of moderate hidradenitis suppurativa and highlights the importance of early diagnosis and timely treatment to prevent progression and improve patient outcomes

In this Dermatology Times Partner Perspectives video, Dr. Martina Porter examines the profound psychosocial burden of hidradenitis suppurativa and underscores the importance of early diagnosis and treatment to improve patients’ quality of life.

In this Dermatology Times Partner Perspectives video, Dr. Martina Porter provides an overview of moderate hidradenitis suppurativa—its diagnosis, psychosocial impact, and treatment—highlighting the importance of early recognition and intervention.

Tiffany Mayo, MD, highlights the treatment guidelines in management of patients with hidradenitis suppurativa and discusses the role of biologics in the treatment landscape.

Tiffany Mayo, MD, shares insights regarding disease severity and the role of progression of hidradenitis suppurativa.

Tiffany Mayo, MD, provides an overview of hidradenitis suppurativa and discusses the patient burden and challenges to diagnosis of the disease.

Tiffany Mayo, MD, provides insights and practical tips in patient communication for the diagnosis and management of patients with hidradenitis suppurativa.

Dr. Jonathan Rodrigues highlights challenges in management of patients with chronic spontaneous urticaria and why shared decision-making is critical.

Dr. Jonathan Rodrigues shares insights regarding the assessment of chronic spontaneous urticaria and the impact of delays in diagnosis.

Dr. Jonathan Rodrigues reviews the clinical features of chronic spontaneous urticaria and discusses the evolving understanding of the disease.